Literature DB >> 10585991

The science and fiction of pertussis vaccines.

J D Cherry1, P Olin.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10585991     DOI： 10.1542/peds.104.6.1381

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  12 in total

1.  Adolescent and adult pertussis. A problem and a solution.

Authors:  R Schabas
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

2.  Current and Future Use of Vaccines for Viral and Bacterial Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

3.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

5.  Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.

Authors:  Hans O Hallander; Abdolreza Advani; Declan Donnelly; Lennart Gustafsson; Rose-Marie Carlsson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Authors:  Casandra Hoffman; Joshua Eby; Mary Gray; F Heath Damron; Jeffrey Melvin; Peggy Cotter; Erik Hewlett
Journal:  Mol Microbiol       Date:  2016-11-03       Impact factor: 3.501

Review 7.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine.

Authors:  Roland Sänger; Ulrich Behre; Karl-Heinz Krause; Hans-Peter Loch; Peter Soemantri; Dietmar Herrmann; Eugenie Schmitz-Hauss; Joanne Wolter; Bernard Hoet
Journal:  Eur J Pediatr       Date:  2007-01-18       Impact factor: 3.183

9.  Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.

Authors:  Marie-Louise von Linstow; Peter Lotko Pontoppidan; Carl-Heinz Wirsing von König; James D Cherry; Birthe Hogh
Journal:  Eur J Pediatr       Date:  2010-04-08       Impact factor: 3.183

10.  A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Authors:  Manoj Gambhir; Thomas A Clark; Simon Cauchemez; Sara Y Tartof; David L Swerdlow; Neil M Ferguson
Journal:  PLoS Comput Biol       Date:  2015-04-23       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.